Great Point Partners’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-68,158
Closed -$497K 40
2015
Q1
$497K Sell
68,158
-486,268
-88% -$3.98M 0.22% 30
2014
Q4
$5.36M Sell
554,426
-52,870
-9% -$413K 2.58% 14
2014
Q3
$5.92M Buy
607,296
+146,086
+32% +$1.92M 2.54% 19
2014
Q2
$7.9M Buy
461,210
+150,962
+49% +$2.17M 3.51% 12
2014
Q1
$5.32M Sell
310,248
-43,677
-12% -$698K 2.78% 14
2013
Q4
$5.13M Buy
+353,925
New +$4.61M 3.62% 12

Other funds holding VCYT

Great Point Partners's VCYT Position: Q2 2015 in Review

Great Point Partners sold out of Veracyte (VCYT) in Q2 2015, closing a stake of 68,158 shares — an estimated $497K sold.

Great Point Partners first reported a position in VCYT in Q4 2013 and held it in 6 quarters. The position peaked at $7.9M in Q2 2014. 60 funds tracked by Wall St. Rank hold VCYT as of Q2 2015.

  • Great Point Partners reported no remaining Veracyte position as of Q2 2015 after selling out during the quarter.
  • Great Point Partners sold 68,158 Veracyte shares in Q2 2015, an estimated $497K.
  • Great Point Partners first reported a position in Veracyte in Q4 2013 and held it in 6 quarters.
  • Great Point Partners's Veracyte position peaked at $7.9M in Q2 2014.
  • 60 funds tracked by Wall St. Rank held Veracyte as of Q2 2015.

Based on Great Point Partners's 13F filing for Q2 2015, filed 14 Aug 2015.